Literature DB >> 230102

Guanyl nucleotide regulation of hormonally-responsive adenylyl cyclases.

J Abramowitz, R Iyengar, L Birnbaumer.   

Abstract

A large number of hormones and neurotransmitters activate adenylyl cyclase [ATP, pyrophosphate lyase (cyclizing; EC 4.6.1.1.)] catalyzing the formation of cAMP and PPi from ATP in the presence of Mg2+. The cAMP formed is in turn responsible for eliciting the physiological responses of these hormones and neurotransmitters. In addition to hormones and neurotransmitters, fluoride ion, cholera toxin and guanyl nucleotides (GTP and GTP analogs such as GTP gamma S and GMP-P(NH)P) also stimulate adenylyl cyclase activity (Perkins, 1974; Birnbaumer, 1977; Gill, 1977). It has become evident that hormonally-responsive adenylyl cyclase is a multi-component system consisting of at least 3 physically distinct units. The first is the hormone receptor containing a specific site for a given hormone. The second is the catalytic moiety (C component) of adenylyl cyclase bearing the site responsible for catalysis of the cyclizing reaction. The third is the guanyl nucleotide regulatory subunit (G component) which binds guanyl nucleotide. Recently, a GTPase activity has been found to be associated with the G component of adenylyl cyclase (Cassel and Selinger, 1976; Cassel et al., 1977a, b; Lambert et al., 1979). In this review we will present information on the regulation of hormonally-responsive adenylyl cyclases. This is not intended to be a comprehensive review of the literature. Rather, it represents our views on the current status of the regulation of cAMP formation.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 230102     DOI: 10.1016/0303-7207(79)90022-4

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  6 in total

1.  Comparative genomics uncovers novel structural and functional features of the heterotrimeric GTPase signaling system.

Authors:  Vivek Anantharaman; Saraswathi Abhiman; Robson F de Souza; L Aravind
Journal:  Gene       Date:  2010-12-20       Impact factor: 3.688

2.  Acceleration of the adipocyte adenylate cyclase turn-off reaction by inhibitory hormonal factors.

Authors:  K H Jakobs; K Aktories; G Shultz
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

3.  Specific demonstration of rat brain adenylate cyclase in polyacryl amide microgels by a new histochemical procedure.

Authors:  G Poeggel; H G Bernstein; H Luppa; D Bischoff
Journal:  Histochemistry       Date:  1981

4.  High skeletal muscle adenylate cyclase in malignant hyperthermia.

Authors:  J H Willner; C G Cerri; D S Wood
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

5.  Naturally soluble component(s) that confer(s) guanine nucleotide and fluoride sensitivity to adenylate cyclase.

Authors:  M K Bhat; R Iyengar; J Abramowitz; M E Bordelon-Riser; L Birnbaumer
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

6.  Interaction of vasoactive intestinal peptide with a cell line (HeLa) derived from human carcinoma of the cervix: binding to specific sites and stimulation of adenylate cyclase.

Authors:  J C Prieto; J M Guerrero; C de Miguel; R Goberna
Journal:  Mol Cell Biochem       Date:  1981-07       Impact factor: 3.396

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.